Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia

Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.